Wall Street Analyst Upgrades to Watch

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  28 May 2026
 

$ECL moved back into focus after UBS upgraded the stock to Buy from Neutral and raised its price target to $325 from $293, arguing that pricing acceleration in the second half of 2026 could support a higher valuation multiple. The firms thesis centers on Ecolabs ability to offset raw material costs through stronger pricing while potentially gaining market share via its OneECL initiatives. UBS also pointed to the companys growing exposure to higher-growth end markets, with annual volume growth potentially improving to 4% versus its historical 1% to 2% range. Jefferies maintained a Buy rating earlier this month while trimming its target slightly to $345 from $352, citing confidence in Ecolabs Circle-the-Customer operating model and projecting 5.1% sales CAGR alongside 11.5% EPS CAGR through 2028.

$A posted one of the strongest reactions among large-cap life sciences names after BofA upgraded Agilent Technologies to Buy from Neutral following what the firm described as an impressive quarterly beat. The stock surged 18.76% to $137.56 on volume that reached roughly double its average daily activity, signaling aggressive repositioning after months of muted sentiment around tools and diagnostics demand. BofA lowered its target slightly from $150 to $145, but the upgrade itself indicated confidence that underlying execution and demand trends are stabilizing faster than investors expected.

$SNOW extended its sharp momentum reversal after BTIG raised its price target to $280 from $235 while maintaining a Buy rating. Shares closed at $243.97 after rallying 39.22% in exceptionally heavy trading volume of 32.8 million shares versus average daily volume of 7.66 million. The move followed renewed optimism around enterprise AI spending and improving demand trends tied to cloud data infrastructure.

$SNPS also received upward target revisions as Piper Sandler increased its target on Synopsys to $450 from $430 while maintaining a Neutral rating. Shares closed at $474.12 after declining 9.88%, materially above the revised target despite continued strength in semiconductor and AI infrastructure spending themes. The call reflects a more cautious valuation stance rather than deterioration in the companys core positioning within chip design software.

$OKTA gained additional support after Arete upgraded the cybersecurity company to Buy. Shares rose 6.27% to $96.27 with trading volume above normal levels. Unlike some of the more momentum-driven AI names, the Okta call was tied primarily to improving sentiment around execution and operational stability after a prolonged period of investor skepticism.

$GRAB attracted renewed bullish attention after receiving a Strong Buy rating upgrade tied to conviction around its long-term operating leverage potential. Shares traded at $3.56 with implied upside toward $6.94, representing one of the largest projected return profiles among the names upgraded today. Despite declining 2.47% during the session, the company continued to trade with elevated liquidity at nearly 30 million shares.

View all market intelligence →